Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLF-CB vs Bev-FOLFOX in First Line Metastatic Colorectal Cancer
NCT00252564Phase 3Completed
- Sponsor
- US Oncology Network
- Start
- Sep 2005
- Primary completion
- Jun 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of KL-140 in metastatic colorectal cancer (mCRC), sponsored by US Oncology Network. Started Sep 2005; status: completed.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00252564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252564.